Indexado en

Licencia y uso

Citaciones

Cited 7 times in

Cited 7 times in

Cited 4 times in

Altmetrics

Grant support

This work was funded by the by the British Heart Foundation Chair of Translational Cardiovascular Sciences (CH/11/2/28733), and by a Biotechnology and Biological Sciences Research Council Grant (BB/L027933/1). This work was further supported by the European Commission (FP7 IAPP 324325). We are grateful to Yvonne Harcus and Gregor Aitchison for their technical assistance. We would also like to thank Andrew P. Byrnes for supplying the purified mouse IgM used in this study.

Análisis de autorías institucional

Compartir

Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In Vivo

Publicado en:Viruses-Basel. 11 (7): - 2019-07-01 11(7), DOI: 10.3390/v11070616

Autores: Doszpoly A, de la Cuesta F, Lopez-Gordo E, Bénézech C, Nicklin SA, Baker AH

Afiliaciones

Resumen

Human adenovirus 5 (HAdV-5) is used as a vector in gene therapy clinical trials, hence its interactions with the host immune system have been widely studied. Previous studies have demonstrated that HAdV-5 binds specifically to murine coagulation factor X (mFX), inhibiting IgM and complement-mediated neutralization. Here, we examined the physical binding of immune components to HAdV-5 by nanoparticle tracking analysis, neutralization assays, mass spectrometry analysis and in vivo experiments. We observed that purified mouse Immunoglobulin M (IgM) antibodies bound to HAdV-5 only in the presence of complement components. Active serum components were demonstrated to bind to HAdV-5 in the presence or absence of mFX, indicating that immune molecules and mFX might bind to different sites. Since binding of mFX to HAdV-5 blocks the neutralization cascade, these findings suggested that not all complement-binding sites may be involved in virion neutralization. Furthermore, the data obtained from serum neutralization experiments suggested that immune molecules other than IgM and IgG may trigger activation of the complement cascade in vitro. In vivo experiments were conducted in immunocompetent C57BL/6 or immuno-deficient Rag2-/- mice. HAdV-5T* (a mutant HAdV-5 unable to bind to human or mFX) was neutralized to some extent in both mouse models, suggesting that murine immunoglobulins were not required for neutralization of HAdV-5 in vivo. Liquid Chromatography-Mass Spectrometry (LC-MS/MS) analysis of HAdV-5 and HAdV-5T* after exposure to murine sera showed stable binding of C3 and C4b in the absence of mFX. In summary, these results suggest that HAdV-5 neutralization can be mediated by both the classical and alternative pathways and that, in the absence of immunoglobulins, the complement cascade can be activated by direct binding of C3 to the virion.

Palabras clave